
(AGENPARL) – SILVER SPRING ven 02 giugno 2023 On May 16 and 17, 2022, the FDA’s Center for Drug Evaluation and Research (CDER) and NIH’s National Center for Advancing Translational Sciences (NCATS) will host a jointly sponsored virtual workshop to explore regulatory fitness in rare disease clinical trials.
Fonte/Source: http://www.fda.gov/drugs/news-events-human-drugs/fda-cder-nih-ncats-regulatory-fitness-rare-disease-clinical-trials-workshop-05162022